| Junk food-induced obesity-a growing threat to youngsters during the pandemic A Singh, D Dhanasekaran, N Ganamurali, L Preethi, S Sabarathinam Obesity Medicine 26, 100364, 2021 | 55 | 2021 |
| Therapeutic use of Guggulsterone in COVID-19 induced obesity (COVIBESITY) and significant role in immunomodulatory effect L Preethi, N Ganamurali, D Dhanasekaran, S Sabarathinam Obesity Medicine 24, 100346, 2021 | 36 | 2021 |
| Chalcones reloaded: an integration of network pharmacology and molecular docking for type 2 diabetes therapy S Sabarathinam, N Ganamurali Journal of Biomolecular Structure and Dynamics 42 (18), 9505-9517, 2024 | 8 | 2024 |
| A narrative review on the impact of sarcopenic obesity and its psychological consequence in quality of life S Khatoon, D Saravanan, N Ganamurali, S Sabarathinam Diabetes & Metabolic Syndrome: Clinical Research & Reviews 17 (9), 102846, 2023 | 5 | 2023 |
| Junk food-induced obesity-a growing threat to youngsters during the pandemic. Obes Med. 2021; 26: 100364 SA Singh, D Dhanasekaran, N Ganamurali, S Sabarathinam | 5 | 2021 |
| Drug designing and toxicity screening of halogen and nitrogen-augmented catechin in sarcopenic obesity S Sabarathinam, S Satheesh, N Ganamurali, D Dhanasekaran, A Raja Natural Product Research 38 (19), 3438-3443, 2024 | 3 | 2024 |
| HCIP: an online database for prediction CYP450 Enzyme Inhibition Potential of Bioactive Compounds S Sarvesh, L Preethi, H Meganathan, MA Gokulan, D Dhanasekaran, ... Journal of Drug Delivery and Therapeutics 11 (2), 253-255, 2021 | 3 | 2021 |
| Pharmacokinetic correlation of structurally modified chalcone derivatives as promising leads to treat tuberculosis S Sabarathinam, N Ganamurali, S Satheesh, D Dhanasekaran, A Raja Future Medicinal Chemistry 15 (20), 1903-1913, 2023 | 2 | 2023 |
| An exploration of the experience of dapagliflozin in clinical practice AP Anitha, S Balasubramanian, AG Ramalingam, SR Samuel Kennady, ... Future Science OA 8 (8), FSO816, 2022 | 2 | 2022 |
| In Silico Prediction and Pharmacokinetic Comparison of Ursodeoxycholic Acid and Obeticholic Acid in the Management of Primary Biliary Cholangitis MS Dhage, N Ganamurali, D Dhanasekaran, S Sabarathinam Journal of Drug Delivery and Therapeutics 11 (2-S), 113-117, 2021 | 2 | 2021 |
| Insight on sarcopenic obesity and epicatechin as a promising treatment option S Sabarathinam, D Dhanasekaran, N Ganamurali Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 102856, 2023 | 1 | 2023 |
| Artificial sweetener is a growing threat for metabolic syndrome: why is extra attention required? S Sabarathinam, D Dhanasekaran, N Ganamurali Future Science OA 9 (8), FSO880, 2023 | | 2023 |
| Obesity Medicine L Preethi, N Ganamurali, D Dhanasekaran, S Sabarathinam | | |
Sarvesh SabarathinamAssistant Professor-CGHR-Saveetha University在 saveetha.com 的电子邮件经过验证
